Old Web
English
Sign In
Acemap
>
authorDetail
>
Russell M Walker
Russell M Walker
Pathology
Medicine
Pharmacokinetics
Melanoma
Pharmacology
4
Papers
21
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase I, dose-escalation study of the investigational drug TAK-733, an oral MEK inhibitor, in patients (pts) with advanced solid tumors.
2017
Journal of Clinical Oncology
Alex A. Adjei
Patricia LoRusso
Antoni Ribas
Jeffrey A. Sosman
Anna C. Pavlick
Grace K. Dy
Xiaofei Zhou
Esha Gangolli
Russell M Walker
Michelle Kneissl
Stephanie Faucette
Rachel Neuwirth
Viviana Bozon
Show All
Source
Cite
Save
Citations (6)
MLN2480, an investigational oral pan-RAF kinase inhibitor, in patients (pts) with relapsed or refractory solid tumors: Phase I study.
2013
Journal of Clinical Oncology
Drew W. Rasco
Anthony J. Olszanski
Amita Patnaik
Guillermo Espino
Rachel Neuwirth
Stephanie Faucette
Michael Bargfrede
Esha Gangolli
Russell M Walker
Michelle Kneissl
Viviana Bozon
Show All
Source
Cite
Save
Citations (7)
First-in-human, multicenter, dose-escalation, phase I study of the investigational drug TAK-733, an oral MEK inhibitor, in patients (pts) with advanced nonhematologic malignancies and melanoma.
2011
Journal of Clinical Oncology
J. A. Sosman
A. A. Adjei
Patricia LoRusso
Shaunita A. Michael
G. K. Dy
A. Bowditch
Bartosz Chmielowski
Sandra J. Lee
Russell M Walker
Stephanie Faucette
Elena Izmailova
Viviana Bozon
Antoni Ribas
Show All
Source
Cite
Save
Citations (4)
Internet-Based Calibration of a Multifunction Calibrator
2000
Lisa A. Bunting Baca
Leonard E. Duda Jr.
Russell M Walker
Nile M. Oldham
Mark E. Parker
Show All
Source
Cite
Save
Citations (4)
1